New risk factors for atherosclerosis in hypertension: focus on the prothrombotic state and lipoprotein(a)

Related Experiment Videos

Cristiana Catena1, Marileda Novello, Roberta Lapenna

  • 1Internal Medicine and Hypertension Unit, Department of Experimental and Clinical Pathology and Medicine, University of Udine, Piazzale S. Maria della Misericordia, 33100 Udine, Italy.

Journal of Hypertension
|August 12, 2005
PubMed

Insights

Hypertension management requires addressing emerging risks like prothrombotic states and lipoprotein(a) for better cardiovascular prevention. Identifying these factors improves prediction of atherothrombotic events in high blood pressure patients.

Area of Science:

  • Cardiology
  • Hypertension Research
  • Preventive Medicine

Background:

  • Adequate blood pressure control is crucial for cardiovascular prevention in hypertensive patients.
  • Traditional risk factors do not fully explain all premature cardiovascular events, indicating the need for novel risk factor identification.
  • Despite interventions, cardiovascular morbidity and mortality remain high, emphasizing the importance of comprehensive risk assessment.

Purpose of the Study:

  • To review the biology and clinical evidence of two emerging cardiovascular risk factors in hypertension: prothrombotic state and lipoprotein(a).
  • To highlight the reciprocal relationship between these factors and their contribution to organ damage in hypertensive individuals.
  • To emphasize the importance of considering novel risk factors for improved prediction of atherothrombotic events.

Main Methods:

  • Literature review of basic biology and clinical evidence.
  • Analysis of epidemiological research identifying novel cardiovascular risk factors.
  • Synthesis of information on the role of prothrombotic state and lipoprotein(a) in hypertension.

Main Results:

  • Prothrombotic state and lipoprotein(a) are identified as significant emerging risk factors in hypertension.
  • These factors are reciprocally related and contribute to the development and progression of organ damage.
  • Incorporating these novel factors into risk assessment may enhance the prediction of atherothrombotic events.

Conclusions:

  • Hypertension management must integrate the assessment of novel risk factors beyond traditional ones.
  • Prothrombotic state and lipoprotein(a) warrant consideration due to their impact on cardiovascular risk and organ damage.
  • Further research and clinical attention to these emerging factors are essential for advancing cardiovascular prevention strategies.

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...